Audrey Zhi advises companies on anti-corruption compliance, investigations, and regulatory compliance, with a particular focus on life science companies. She has experience in conducting highly sensitive investigations related to anti-corruption/FCPA, fraud, conflict of interest, anti-counterfeiting and brand protection, as well as in compliance program assessments, risk assessments, FCPA and compliance and regulatory due diligence in transactions, company compliance and employment litigations. Her work spans industries including life sciences, consumer products, semiconductors, technology, beverage, energy, automotive, sports, e-commerce, and conglomerates.
Audrey also has experience advising multinational companies on corporate and regulatory matters and transactions, including contract drafting and review, mergers and acquisitions, due diligence, foreign direct investments, outbound investments, and employment. Her work focuses on the life science industry, including pharmaceuticals, medical device, in vitro diagnostics, companion diagnostics, cosmetics, and food.